Home / Import refusals / T50-0220273-3/1/1

FDA Import Refusal T50-0220273-3/1/1 — Hikma Pharmaceuticals LLC

Hikma Pharmaceuticals LLC — FEI 3002806351

The FDA refused shipment T50-0220273-3/1/1 from Hikma Pharmaceuticals LLC (Jordan) on December 31, 2002. The refused product falls under Drugs and Biologics — NAPROXEN SODIUM (ANTI-INFLAMMATORY). Cited charge: 16 This firm has 5 or more other import refusals on record.

Refusal Details

Date
December 31, 2002
Country
Jordan
Product Category
Drugs and Biologics
Product Code
62GCZ50 NAPROXEN SODIUM (ANTI-INFLAMMATORY)
Charges
16

Recent inspections

  • 1101407 (VAI Thu Sep 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 981353 (VAI Wed Jul 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 935111 (VAI Thu Jun 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 782232 (NAI Thu Apr 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 645014 (NAI Thu Feb 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-8936416-1/11/1 (Fri Jan 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-4248675-0/11/1 (Thu Feb 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0801372-1/1/1 (Fri May 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0458162-1/1/1 (Fri Oct 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 071-0160955-5/1/1 (Fri Mar 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources